Ignite Creation Date:
2025-12-24 @ 12:25 PM
Ignite Modification Date:
2025-12-28 @ 11:52 AM
Study NCT ID:
NCT01251861
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-11
First Post:
2010-12-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-12-23
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-03-18
Completion Date Type:
ESTIMATED
First Submit Date:
2010-12-01
First Submit QC Date:
None
Study First Post Date:
2010-12-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-09-25
Results First Submit QC Date:
None
Results First Post Date:
2019-12-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-26
Last Update Post Date:
2025-12-11
Last Update Post Date Type:
ESTIMATED